GENCARO BUCINDOLOL HCL Trademark

Trademark Overview

On Monday, February 4, 2013, a trademark application was filed for GENCARO BUCINDOLOL HCL with the United States Patent and Trademark Office. The USPTO has given the GENCARO BUCINDOLOL HCL trademark a serial number of 85840344. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 17, 2016. This trademark is owned by Arca biopharma, Inc.. The GENCARO BUCINDOLOL HCL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations made in significant part of bucindolol hcl, for use in the treatment of diseases and disorders in the cardiovascular, vascular and hematology fields
gencaro bucindolol hcl

General Information

Serial Number85840344
Word MarkGENCARO BUCINDOLOL HCL
Filing DateMonday, February 4, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 17, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 16, 2013

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BUCINDOLOL HCL"
Description of MarkThe mark consists of an image of heart with the words "GENCARO BUCINDOLOL HCL" to the right.
Goods and ServicesPharmaceutical preparations made in significant part of bucindolol hcl, for use in the treatment of diseases and disorders in the cardiovascular, vascular and hematology fields

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 8, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArca biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWestminster, CO 80020
Party NameArca biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBroomfield, CO 80021

Trademark Events

Event DateEvent Description
Monday, October 17, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 17, 2016ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 11, 2016EXTENSION 5 GRANTED
Thursday, March 10, 2016EXTENSION 5 FILED
Thursday, March 10, 2016TEAS EXTENSION RECEIVED
Tuesday, September 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 14, 2015EXTENSION 4 GRANTED
Thursday, September 10, 2015EXTENSION 4 FILED
Thursday, September 10, 2015TEAS EXTENSION RECEIVED
Thursday, August 6, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 6, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, July 26, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, July 26, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 17, 2015EXTENSION 3 GRANTED
Monday, March 9, 2015EXTENSION 3 FILED
Monday, March 9, 2015TEAS EXTENSION RECEIVED
Tuesday, September 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 20, 2014EXTENSION 2 GRANTED
Wednesday, September 10, 2014EXTENSION 2 FILED
Friday, September 19, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 10, 2014TEAS EXTENSION RECEIVED
Wednesday, March 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 10, 2014EXTENSION 1 GRANTED
Monday, March 10, 2014EXTENSION 1 FILED
Monday, March 10, 2014TEAS EXTENSION RECEIVED
Tuesday, September 10, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 16, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2013PUBLISHED FOR OPPOSITION
Wednesday, June 26, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 10, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 10, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 10, 2013EXAMINER'S AMENDMENT ENTERED
Monday, June 10, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 10, 2013EXAMINERS AMENDMENT E-MAILED
Monday, June 10, 2013EXAMINERS AMENDMENT -WRITTEN
Friday, June 7, 2013PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, May 28, 2013WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, May 15, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 15, 2013ASSIGNED TO LIE
Monday, May 6, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 6, 2013EXAMINER'S AMENDMENT ENTERED
Monday, May 6, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 6, 2013EXAMINERS AMENDMENT E-MAILED
Monday, May 6, 2013EXAMINERS AMENDMENT -WRITTEN
Friday, May 3, 2013ASSIGNED TO EXAMINER
Saturday, February 9, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, February 8, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 7, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

bucindolol gencaro cardiovascular disorders vascular hematology fields diseases treatment made preparations significant